Advertisement
Screener

Prime Medicine, Inc. (PRME) Auditor

Prime Medicine, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-03: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
  • 2025-02-28: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
  • 2024-03-01: Fiscal year end 2023-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
  • 2023-03-09: Fiscal year end 2022-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-032025-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2025-02-282024-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2024-03-012023-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2023-03-092022-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B